Brie Carter

Main Street Capital (NYSE:MAIN) provided a preliminary look at its first-quarter 2026 performance today, indicating continued growth in its intrinsic value.

Digital health pioneer BlinkLab (ASX:BB1) secured $17.5 million through an oversubscribed share placement.

Xenitra (ASX:XEN) reported a preliminary unaudited sales increase of over 300% for the third quarter.

Kali Metals (ASX:KM1) launched a Phase 2 reverse circulation drilling programme at the Marble Bar Lithium Project.

Genesis Minerals (ASX:GMD) saw its cash and equivalents surge by $196 million in the March quarter, bringing its total treasury to $600 million.

Boxlight (NASDAQ:BOXL), a leading provider of interactive technology and integrated school communications, today announced its financial results for the fourth quarter and full year ended December 31, 2025.

Prologis (NYSE:PLD), the global leader in logistics real estate, today reported a robust set of financial results for the first quarter of 2026, highlighted by a significant earnings jump and a strategic pivot toward digital infrastructure.

Eli Lilly (NYSE:LLY) reached a landmark milestone in its metabolic health pipeline on April 16, 2026, announcing positive topline results from the Phase 3 ACHIEVE-4 clinical trial.

Aligos Therapeutics (NASDAQ:ALGS), a clinical-stage biopharmaceutical company focused on developing novel therapeutics for viral and liver diseases, announced on April 16, 2026, that it has entered into an exclusive licensing agreement with Xiamen Amoytop Biotech.

BW LPG (NYSE:BWLP), the world’s leading owner and operator of Very Large Gas Carriers (VLGCs), provided an operational update today regarding the first-quarter performance of its trading arm, BW Product Services.